These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26762600)

  • 1. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.
    Peng K; Tian X; Qian Y; Skibba M; Zou C; Liu Z; Wang J; Xu Z; Li X; Liang G
    J Cell Mol Med; 2016 Mar; 20(3):482-94. PubMed ID: 26762600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice.
    Li W; Fang Q; Zhong P; Chen L; Wang L; Zhang Y; Wang J; Li X; Wang Y; Wang J; Liang G
    Sci Rep; 2016 Apr; 6():24580. PubMed ID: 27087279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
    Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
    J Cell Mol Med; 2016 Jan; 20(1):48-57. PubMed ID: 26515045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
    Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II-Induced Kidney Fibrosis.
    Qian Y; Peng K; Qiu C; Skibba M; Huang Y; Xu Z; Zhang Y; Hu J; Liang D; Zou C; Wang Y; Liang G
    J Pharmacol Exp Ther; 2016 Jan; 356(1):32-42. PubMed ID: 26514795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease.
    Honda Y; Shishido T; Takahashi T; Watanabe T; Netsu S; Kinoshita D; Narumi T; Kadowaki S; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Kishida S; Kadomatsu K; Takeishi Y; Kubota I
    Hypertension; 2016 May; 67(5):857-65. PubMed ID: 26975703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
    Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
    Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New EGFR inhibitor, 453, prevents renal fibrosis in angiotensin II-stimulated mice.
    Skibba M; Qian Y; Bao Y; Lan J; Peng K; Zhao Y; Zhong P; Hu J; Li X; Liang G
    Eur J Pharmacol; 2016 Oct; 789():421-430. PubMed ID: 27497883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
    J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
    Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
    J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
    Chan SL; Umesalma S; Baumbach GL
    Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
    Bouallegue A; Vardatsikos G; Srivastava AK
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
    Chen J; Chen JK; Neilson EG; Harris RC
    J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D; Schmitz U; Kramer HJ
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway.
    Li X; Lee JW; Graves LM; Earp HS
    EMBO J; 1998 May; 17(9):2574-83. PubMed ID: 9564040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells.
    Shimizu H; Hirose Y; Goto S; Nishijima F; Zrelli H; Zghonda N; Niwa T; Miyazaki H
    Life Sci; 2012 Sep; 91(5-6):172-7. PubMed ID: 22781707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
    Zhang S; Lu Y; Jiang C
    J Recept Signal Transduct Res; 2020 Aug; 40(4):339-347. PubMed ID: 32122211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
    Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
    J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.